Seung-Hyun Jeong

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Induced Pluripotent Stem Cells

Structural Basis

Molecular Dynamics

Top Venues

Pharmacotherapy

International journal of molecular sciences

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ji-Hun Jang, Seung-Hyun Jeong
Structure-Based Analysis of Cefaclor Pharmacokinetic Diversity According to Human Peptide Transporter-1 Genetic Polymorphism. International journal of molecular sciences 25 (13) (2024)
Ji-Hun Jang, Seung-Hyun Jeong
Structure-Based Analysis of Cefaclor Pharmacokinetic Diversity According to Human Peptide Transporter-1 Genetic Polymorphism. International journal of molecular sciences 25 (13) (2024)
Ji-Hun Jang, Ho-Suk Kang, Seung-Hyun Jeong
Population Pharmacokinetics of Loxoprofen and its alcoholic metabolites in healthy Korean men. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2024)
Ji-Hun Jang, Seung-Hyun Jeong
Structure-Based Analysis of Cefaclor Pharmacokinetic Diversity According to Human Peptide Transporter-1 Genetic Polymorphism. International journal of molecular sciences 25 (13) (2024)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43 (2) (2023)
Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy (2023)